Navigation Links
Afinitor (Breast Cancer) - Analysis and Forecasts to 2020

ints shaping and defining the markets

- In-depth analysis of Afinitor including efficacy, safety, pricing, competition and other details which influence its sales potential

- Detailed sales forecast for 2013-2020 for Afinitor in the seven major markets

Reasons to buy

- Understand and capitalize by identifying products that are most likely to ensure a robust return

- Stay ahead of competition by understanding the changing competitive landscape

- Effectively plan your M&A and partnership strategies by identifying drugs with the most promising sales potential

- Make more informed business decisions from insightful and in-depth analysis of the drug's performance

- Examine the historical sales performance of a drug in seven major markets

- Obtain sales forecast for currently marketed/pipeline drug for 2011-2020 for all seven major markets

1 Table of Contents 2

1.1 List of Tables 3

1.2 List of Figures 3

2 Introduction 5

2.1 Breast Cancer Market 5

2.2 Epidemiology 5

2.3 GlobalData Report Guidance 7

3 Breast Cancer: Market Characterization 8

3.1 Breast Cancer Market 8

3.2 Breast Cancer Market Forecasts and CAGR 8

3.3 Drivers of Breast Cancer Market 9

3.3.1 High Prevalence 9

3.3.2 Breast Cancer: Most Frequent Cancer in Women 9

3.3.3 Increasing Breast Cancer Incidence Rate 10

3.3.4 Decreasing Breast Cancer Mortality Rate 11

3.3.5 High Survival Rates of Breast Cancer 13

4 Staging of Breast Cancer: Introduction 15

4.1 Distribution of Patients by Stages 15

4.1.1 Stages 15

5 Predictive Biomarker in the Treatment of Breast Cancer 18

6 Treatment Options of Breast Cancer 20

6.1 Stage 0 Breast Cancer: Treatment Options 20

6.2 Early Stage Breast Cancer (Excluding Stage 0) 21

6.3 Metastatic Breast Cancer (MBC) 23

6.3.1 Endocrine Treatment:

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Novartis Drug Afinitor® Effective in Patients With Non-Cancerous Kidney Tumors Associated With TSC in Phase III Trial
2. Phase III Trial of Novartis Drug Afinitor® Met Primary Endpoint of Reducing SEGA Tumor Size in Patients With Tuberous Sclerosis
3. FDA Approves Novartis Drug Afinitor to Treat Pancreatic Neuroendocrine Tumors
4. Novartis Gains FDA Approval for Afinitor® as First New Treatment in Nearly Three Decades for Patients with Advanced Pancreatic NET
5. Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin
6. Study Shows Novartis Drug Afinitor® Plus Hormonal Therapy Delays Disease Progression in Advanced Metastatic Breast Cancer Patients
7. Study in NEJM Shows Novartis Drug Afinitor® Reduces Size of SEGAs, Benign Brain Tumors Associated with Tuberous Sclerosis
8. FDA Approves New Indication for Afinitor
9. VIDEO from and Novartis: Novartis drug Afinitor® Approved by FDA as First Medication for Children and Adults With a Benign Brain Tumor Associated With Tuberous Sclerosis
10. Pivotal Phase III Trial of Novartis Drug Afinitor® Met Primary Endpoint in Study of Patients With Advanced Pancreatic Neuroendocrine Tumors
11. Afinitor(R) Phase II Data Show Positive Results for Patients With Multiple Types of Lymphoma, Leading to Phase III Trial
Post Your Comments:
(Date:1/15/2014)... and Markets ( ) has announced the addition ... Analysis, Size, Share, Growth, Trends And Forecast, 2013 - ... (Logo: ) Dental ... order to treat dental impairments, for tooth restoration and ...
(Date:1/15/2014)...  Novation, the leading health care supply chain expertise, analytics ... (VAR) national contracts that expand its portfolio to provide ... costs. These include manufacturer product and service agreements, as ... ongoing IT consulting support. New Novation ...
(Date:1/15/2014)... January 15, 2014 Shire plc (LSE: SHP, NASDAQ: ... of Fair Trading (OFT) approval condition to the announced tender offer ...   As a result of the waiver, the transaction ... complete the tender offer on January 24, 2014 following the currently ...
Breaking Medicine Technology:Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018 2Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018 3New Novation Information Technology VAR Contracts Offer Significant Savings to Hospitals 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 3
... Everist Genomics, a rapidly growing personalized medicine company ... today that it has successfully completed acquisition of ... developer of the AngioDefender™ diagnostic device for assessing ... biomarker of early-stage atherosclerosis and CVD; it is ...
... 31, 2011 Baxano, Inc., a Silicon Valley based ... for spinal decompression surgery, announces a rapid expansion of ... its products. This continued expansion in ... new and existing accounts throughout the U.S. while providing ...
Cached Medicine Technology:Everist Genomics Announces Acquisition of Angiologix, Inc. 2Everist Genomics Announces Acquisition of Angiologix, Inc. 3Everist Genomics Announces Acquisition of Angiologix, Inc. 4Everist Genomics Announces Acquisition of Angiologix, Inc. 5Baxano Rapidly Expands Sales Force to Support Robust Demand for the iO-Flex® System 2
(Date:4/18/2014)... have made a brain-related discovery that could revolutionize ... This discovery opens up the possibility that environmental ... specific brain activity that the researchers have identified ... Journal of Neuroscience has just published a ... associate professor of psychology and his doctoral student ...
(Date:4/18/2014)... to potential new treatments for breaking the cycle of ... or scarring, is a hallmark of the disease, and ... to serious organ damage and, in some cases, death. ... findings made by Swati Bhattacharyya, PhD, research assistant professor ... protein plays in promoting fibrosis. , "Our results ...
(Date:4/17/2014)... have identified the first genetic variant specifically associated ... accounting for around 10-15 per cent of all ... of the breast cancer sub-type, called invasive lobular ... causes of this particular kind of breast cancer, ... research, published today (Thursday) in the journal ...
(Date:4/17/2014)... According to a study published today in PLOS ... world where malaria is common can mount an immune ... them to avoid repeated bouts of high fever and ... in their bloodstream. The findings may help researchers develop ... by the malaria parasite. , Each year, approximately 200 ...
(Date:4/17/2014)... Two recent papers by a University of Colorado ... scientists develop treatments or vaccines for Dengue fever, ... other disease-causing flaviviruses. , Jeffrey S. Kieft, PhD, ... the School of Medicine and an early career ... colleagues recently published articles in the scholarly journals ...
Breaking Medicine News(10 mins):Health News:Scientists discover brain's anti-distraction system 2Health News:New clues on tissue scarring in scleroderma 2Health News:First genetic link discovered to difficult-to-diagnose breast cancer sub-type 2Health News:First genetic link discovered to difficult-to-diagnose breast cancer sub-type 3Health News:Study sheds light on how the immune system protects children from malaria 2Health News:CU researchers discover target for treating dengue fever 2
... Reporter , TUESDAY, April 3 (HealthDay News) -- Several Rhode ... of sharp wire bristles that made their way from barbecue ... which came from the metallic brushes used to clean grills, ... patients ate, a new report said. From there, the bristles ...
... used by cancer and transplant patients, and there are hints that it ... it also comes with a downside: rapamycin leads to diabetes in as ... Now, researchers reporting in the April Cell Metabolism , a Cell ... insulin signal off in muscle, to prevent muscle cells from taking blood ...
... TUESDAY, April 3 (HealthDay News) -- A vaccination may help ... small new study reports. The prognosis for many ... is the only effective treatment, although there has been hope ... The results of the new study, which included 27 children ...
... blood vessels earlier than previously thought, and these structural ... the development of high blood pressure. These findings in ... of Virginia School of Medicine in the US, are ... Research . With age, increasing weight and metabolic ...
... Women having children at older ages and the growing availability ... the birth of twins: In 2009, one in every 30 ... with one in every 53 in 1980. The findings, ... the 14th Congress of the International Society of Twin Studies ...
... is a disconnect between the number of cancer patients estimated to ... for orthopedic care each year, states an article in the ... 140 000 new cases of cancer diagnosed in Canada each year ... are referred to orthopedic services even though they could benefit in ...
Cached Medicine News:Health News:BBQ Danger: Wires From Grill Cleaners Swallowed in Food 2Health News:BBQ Danger: Wires From Grill Cleaners Swallowed in Food 3Health News:How a cancer drug leads to diabetes 2Health News:Study Suggests Vaccine May Help Kids With Brain Cancer 2Health News:Arteries under pressure early on 2Health News:Seeing double: 1 in 30 babies born in US is a twin 2
The VISULAS 532s combines ease of use, efficiency and safety to provide ophthalmologists with an overall system sharply focused on their requirements. ,The VISULAS 532s is a laser of many talent...
Two point fixation, tips separated by 13 mm. Each tip has 0.12 mm, 1 x 2 teeth. Flat serrated handle with polished finish. Without lock....
... A simple, effective method for determining ... Provides reliable data which can be applied ... problems. The set consists of four trays ... reference caps that have incremental hue variation ...
... D15 test evaluation has a choice ... caps with automatic creation 'horse-shoe' diagrams, ... deficiency analysis, calculation of color confusion ... eye selection (OD, OS, OU) and ...
Medicine Products: